Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 100,000 shares at $35.34 ($3.5M) on 2023-02-22, disclosed to the SEC on 2023-02-28.
Open-market sale of $3.5M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.70 | 47,888 | $1.7M | 47.9% |
| 2 | $34.70 | 47,888 | $1.7M | 47.9% |
| 3 | $35.34 | 2,112 | $75K | 2.1% |
| 4 | $35.34 | 2,112 | $75K | 2.1% |
| Total | $34.73 avg | 100,000 | $3.5M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |